doi: 10.1093/jacamr/dlab053.
eCollection 2021 Jun.
Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice
Affiliations
- PMID: 34223150
- PMCID: PMC8251257
- DOI: 10.1093/jacamr/dlab053
Item in Clipboard
Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice
JAC Antimicrob Resist.
.
Erratum in
-
Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja® (cefiderocol) in UK clinical practice: introduction; Antibiotic resistance during and beyond COVID-19; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of 'Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients'.JAC Antimicrob Resist. 2021 Aug 28;3(3):dlab109. doi: 10.1093/jacamr/dlab109. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34466802 Free PMC article.
-
Erratum to: Education: The role of the first siderophore cephalosporin Fetcroja® (cefiderocol) in UK clinical practice: introduction; Education: An introduction to the core data for cefiderocol with reflections for a possible role within UK clinical practice; Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa; Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection; Education: An overview from the author of 'Cefiderocol as rescue therapy for Acinetobacter baumannii and other carbapenem-resistant Gram-negative infections in intensive care unit patients'.JAC Antimicrob Resist. 2021 Aug 28;3(3):dlab110. doi: 10.1093/jacamr/dlab110. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34466803 Free PMC article.
Abstract
The video in this section is a copy of a recorded webinar organized by Shionogi to launch cefiderocol to the UK market in September 2020. Dr Andreas Karas presents the key clinical data for this new antibiotic for MDR Gram-negative infections, followed by reflections from Professor Jonathan Edgeworth on the potential use of the new agent in UK clinical practice. Included in the latter is a case study example of a compassionate use case using cefiderocol.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
LinkOut - more resources
Full Text Sources